(a).
Antimicrobial agent | Number of very major errors (%) | Number of major errors (%) | Number of minor errors (%) | AST agreement (%) | Total |
---|---|---|---|---|---|
Gram-positives | |||||
Ampicillin | 0/2 | 1/2 (50.0) | 0/4 | 3/4 (75.0) | 4 |
Ceftaroline | 0/0 | 0/3 | 0/3 | 3/3 (100.0) | 3 |
Doxycycline | 0/0 | 0/2 | 0/2 | 2/2 (100.0) | 2 |
Erythromycin | 0/1 | 0/2 | 0/3 | 3/3 (100.0) | 3 |
Trimethoprim-sulfamethoxazole | 0/0 | 0/3 | 0/3 | 3/3 (100.0) | 3 |
Daptomycin | 0/0 | 0/5 | 0/5 | 5/5 (100.0) | 5 |
Linezolid | 0/0 | 0/7 | 0/7 | 7/7 (100.0) | 7 |
Vancomycin | 0/1 | 1/6 (16.7) | 0/7 | 6/7 (85.7) | 7 |
Cefoxitin | 0/0 | 0/2 | 0/2 | 2/2 (100.0) | 2 |
MLS screening | 0/0 | 0/2 | 0/2 | 2/2 (100.0) | 2 |
Total | 0/4 | 2/34 (5.9) | 0/38 | 36/38 (94.7) | 38 |